Another study conducted by Rosich and colleagues on mantle cell lymphoma (MCL) revealed that autophagy was upregulated in MCL cells refractory to a combinatory treatment with everolimus (an mTOR inhibitor) and an Akt inhibitor. This evidence concerns the gene AKT1 and mantle cell lymphoma.